08:58:33 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande


2024-03-28 Årsstämma 2024
2024-02-15 Bokslutskommuniké 2023
2023-10-26 Kvartalsrapport 2023-Q3
2023-08-24 Kvartalsrapport 2023-Q2
2023-05-03 Kvartalsrapport 2023-Q1
2023-03-30 Ordinarie utdelning SOFTX 0.00 NOK
2023-03-29 Årsstämma 2023
2023-02-17 Bokslutskommuniké 2022
2022-12-09 Extra Bolagsstämma 2022
2022-10-26 Kvartalsrapport 2022-Q3
2022-08-15 Kvartalsrapport 2022-Q2
2022-04-28 Kvartalsrapport 2022-Q1
2022-04-19 Ordinarie utdelning SOFTX 0.00 NOK
2022-04-17 Årsstämma 2022
2022-02-16 Bokslutskommuniké 2021
2021-12-29 Extra Bolagsstämma 2021
2021-11-17 Kvartalsrapport 2021-Q3
2021-09-08 Kvartalsrapport 2021-Q2
2021-04-29 Kvartalsrapport 2021-Q1
2021-04-14 Ordinarie utdelning SOFTX 0.00 NOK
2021-04-13 Årsstämma 2021
2021-02-09 Bokslutskommuniké 2020
2020-12-14 Kvartalsrapport 2020-Q3
2020-09-30 Kvartalsrapport 2020-Q2
2020-07-01 Ordinarie utdelning SOFTX 0.00 NOK
2020-06-30 Kvartalsrapport 2020-Q1
2020-06-30 Årsstämma 2020
2019-12-20 Extra Bolagsstämma 2019
2019-06-27 Årsstämma 2019
2019-06-03 Ordinarie utdelning SOFTX 0.00 NOK
2018-07-02 Split SOFTX 1:50


ListaMERK Equities
SoftOx Solutions är ett norskt medicintekniskt bolag. Bolaget har utvecklat en egenpatenterad lösning baserad på ättiksyra för behandling av kroniska sår hos patienter. Lösningen används för att eliminera infektioner i samband med biofilmer, vilket består av olika kluster av bakterier. En del av läkemedelsutvecklingen sker i samarbete med övriga forskningsinstitut. SoftOx Solutions etablerades under 2012 och har sitt huvudkontor i Oslo.
2022-05-18 15:06:19
SoftOx Solutions AS (SoftOx), a clinical-stage biopharmaceutical and medical
technology company based in Norway, announces that it will attend and host an
educational symposium at the European Wound Management Association (EWMA)
Conference in Paris, France, from 23-25 May 2022.

The European Wound Management Association (EWMA) is a European not-for-profit
umbrella organisation, linking national wound management organisations,
individuals and groups with interest in wound care. EWMA was established in 1991
as a charity organisation registered in the UK.

The EWMA is focused on supporting the implementation of interdisciplinary and
cost effective wound care of high quality. EWMA works to reach its objectives by
being an educational resource, organising conferences, contributing to
international projects related to wound management, actively supporting the
implementation of existing knowledge within wound management, and providing
information on all aspects of wound management.

SoftOx will be hosting a symposium titled 'Future practical solutions for
fighting antimicrobial resistance in wound care', which will take place on
Wednesday, 25 May 2022, from 12.15-13.15 CEST.

"Microbial resistance is one of the most major threats to human health.
Navigating this challenging field of research, we are excited to host a
symposium homing in on how we manage antimicrobial resistance in wound care and,
importantly, promising and cutting-edge research," said Geir Almås, CEO SoftOx
Solutions AS.

At the Joint EWMA & Journées Cicatrisations Conference, SoftOx will be an
exhibitor and presenter. The SWIS-02 study has been selected for oral
presentation by its principal investigator, and CEO Geir Almås will present on
the EXCITE International approach and participate in a meet-the-experts session
as an EXCITE International advisory council member.

Symposium details:
Title: Future practical solutions for fighting antimicrobial resistance in wound
Date and time: Wednesday, 25 May 2022, 12:15 - 13:15 hrs

Speakers and agenda:

o Prof. Niels Frimodt-Møller (Rigshospitalet, Dept. of Clinical Microbiology,
Copenhagen, DK)
Antimicrobial resistance in your practice: an ever more powerful adversary
o Prof. Thomas Bjarnsholt (Copenhagen University Hospital, Dept. of Clinical
Microbiology, Copenhagen, DK)
Countering antimicrobial resistance: its history and mechanism of action
o Dr. Klaus Kirketerp-Møller (Wound Healing Center, Bispebjerg University
Hospital, Copenhagen, DK)
Fighting antimicrobial resistance in wound care tomorrow: clinical research

Chair: Geir Almås, CEO SoftOx Solutions AS

A recording of the symposium will be made available on the Company's website at

For further information, visit the EWMA conference website here:

For further information, please contact:
Geir Almås, CEO of SoftOx Solutions AS
Mail: ir@soft-ox.com
Phone: Front Desk: (+47) 948-59-599

About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian
biotech/medtech company based in Oslo with the aim of helping to combat major
threats to human health, namely the emergence of antimicrobial resistance (AMR),
biofilm infections in chronic wounds and the spread of viruses.
For more information on SoftOx, visit www.soft-ox.com